A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT07256301 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

PNH - Paroxysmal Nocturnal Hemoglobinuria

Interventions

BIOLOGICAL: EA5

Sponsor

Shanghai Lanyi Therapeutics Co., Ltd.